Combined Antioxidant and Glucocorticoid Therapy for Safer Treatment of Preterm Birth

Antenatal glucocorticoid therapy accelerates fetal lung maturation and treatment of the preterm infant with glucocorticoids reduces the incidence of chronic lung disease and the baby’s dependence on assisted ventilation. Therefore, perinatal glucocorticoid therapy has led to a significant reduction in morbidity and mortality of preterm infants